Amyris, Inc., the Emeryville, California-based vertically integrated biomanufacturing company, announced that it will acquire Oobli Inc. of Davis, California, a developer of fermentation-derived sweet proteins that food and beverage brands use to cut sugar while keeping taste.
The transaction pairs Amyris' scientific breadth and manufacturing depth with Oobli's protein fermentation know-how. It follows the capacity expansion Amyris completed earlier this year at its advanced fermentation facility in Barra Bonita, Brazil, and the company described the move as a strategic commercial and technology step that widens its presence in protein- and peptide-based solutions across end markets.
Complementary platforms
"In Oobli, we see a commercial and technology platform that is a great complement to our own," said Amyris chief executive officer Kathy Fortmann. She said Oobli is positioned to change how sweetness reaches the market, and that Amyris intends to apply its commercial scale and resources to accelerate that shift. Combining Oobli's protein expertise with Amyris' strain engineering, manufacturing scale and commercial capabilities, she added, could broaden the combined company's reach in food and beverage, personal care, flavor and fragrance, agriculture and other segments.
What Oobli brings
Oobli's commercial sweet protein portfolio would be the first to draw on the combined platform. The company has spent roughly a decade refining a fermentation process for producing sweet proteins that occur naturally in rare fruits and berries grown near the equator. According to Oobli, these proteins are the first of their kind in the sugar-reduction category: they are hundreds to thousands of times sweeter than sugar, bind directly to sweet taste receptors, and are metabolized by the body as protein, so they deliver sweetness without gut disruption or blood sugar spikes.
The portfolio covers three ingredients:
- Oubli Fruit sweet protein (brazzein)
- Serendipity Berry sweet protein (monellin)
- Katemfe Fruit sweet protein (thaumatin)
Oobli says the ingredients hold FDA GRAS status and are FEMA GRAS-affirmed for use as a natural flavor. With consumer attention to metabolic health and sugar reduction rising, the company positions sweet proteins as a tool brands can apply across sports and nutrition, dairy, beverages, chocolate, bakery and confectionery.
Scale and continuity
"At Oobli, we have always believed there was a better way to deliver the sweet taste consumers love, without the trade-offs to health and our environment," said Oobli chief executive officer Ali Wing. She said joining Amyris gives Oobli the scale and resources to pursue its aim of making sweet proteins a standard in sweetness solutions.
Fortmann said Amyris has seen that biomanufactured solutions win when they align with consumer demand and market needs, and that Oobli's platform does exactly that by addressing sweet taste, sugar reduction and clean label at the same time.
The acquisition is expected to close in the coming weeks. Amyris said all existing customer commitments and brand partnerships will continue to be honored without interruption as the Oobli portfolio is folded into the larger company.
